Cargando…

Correction to: Melatonin and urological cancers: a new therapeutic approach

Detalles Bibliográficos
Autores principales: Pourhanifeh, Mohammad Hossein, Hosseinzadeh, Azam, Juybari, Kobra Bahrampour, Mehrzadi, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523325/
https://www.ncbi.nlm.nih.gov/pubmed/33005099
http://dx.doi.org/10.1186/s12935-020-01564-6
_version_ 1783588364479365120
author Pourhanifeh, Mohammad Hossein
Hosseinzadeh, Azam
Juybari, Kobra Bahrampour
Mehrzadi, Saeed
author_facet Pourhanifeh, Mohammad Hossein
Hosseinzadeh, Azam
Juybari, Kobra Bahrampour
Mehrzadi, Saeed
author_sort Pourhanifeh, Mohammad Hossein
collection PubMed
description
format Online
Article
Text
id pubmed-7523325
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75233252020-09-30 Correction to: Melatonin and urological cancers: a new therapeutic approach Pourhanifeh, Mohammad Hossein Hosseinzadeh, Azam Juybari, Kobra Bahrampour Mehrzadi, Saeed Cancer Cell Int Correction BioMed Central 2020-09-28 /pmc/articles/PMC7523325/ /pubmed/33005099 http://dx.doi.org/10.1186/s12935-020-01564-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Pourhanifeh, Mohammad Hossein
Hosseinzadeh, Azam
Juybari, Kobra Bahrampour
Mehrzadi, Saeed
Correction to: Melatonin and urological cancers: a new therapeutic approach
title Correction to: Melatonin and urological cancers: a new therapeutic approach
title_full Correction to: Melatonin and urological cancers: a new therapeutic approach
title_fullStr Correction to: Melatonin and urological cancers: a new therapeutic approach
title_full_unstemmed Correction to: Melatonin and urological cancers: a new therapeutic approach
title_short Correction to: Melatonin and urological cancers: a new therapeutic approach
title_sort correction to: melatonin and urological cancers: a new therapeutic approach
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523325/
https://www.ncbi.nlm.nih.gov/pubmed/33005099
http://dx.doi.org/10.1186/s12935-020-01564-6
work_keys_str_mv AT pourhanifehmohammadhossein correctiontomelatoninandurologicalcancersanewtherapeuticapproach
AT hosseinzadehazam correctiontomelatoninandurologicalcancersanewtherapeuticapproach
AT juybarikobrabahrampour correctiontomelatoninandurologicalcancersanewtherapeuticapproach
AT mehrzadisaeed correctiontomelatoninandurologicalcancersanewtherapeuticapproach